Heterogeneity and transcriptional drivers of triple-negative breast cancer

Bojana Jovanović(Harvard University), Kornélia Polyák(Dana-Farber Cancer Institute), Laura E. Stevens(Brigham and Women's Hospital), Kodie Garza(Dana-Farber Cancer Institute), Jayati Anand(Dana-Farber Cancer Institute), Malvina Papanastasiou(Broad Institute), Benedetto Diciaccio(Dana-Farber Cancer Institute), Anthony Letai(Dana-Farber Cancer Institute), Anne Trinh(Brigham and Women's Hospital), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Anushree C. Gulvady(Harvard University), Myles Brown(Harvard University), Nicholas W. Harper(Dana-Farber Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), Guillermo Peluffo(Harvard University), Marco Seehawer(Brigham and Women's Hospital), Raga Vadhi(Dana-Farber Cancer Institute), Anne Fassl(Harvard University), Maša Alečković(Princeton University), Robert M. Witwicki(Dana-Farber Cancer Institute), Muhammad B. Ekram(Brigham and Women's Hospital), Jacob D. Jaffe(Broad Institute), Daniel Temko(Harvard University), Shawn B. Egri(Broad Institute), Ashim Subedee(Harvard University), Deborah Dillon(Harvard University), Henry W. Long(Dana-Farber Cancer Institute), Kunihiko Hinohara(Broad Institute), Jason W. Pyrdol(Dana-Farber Cancer Institute), Piotr Siciński(Harvard University), Katherine C. Murphy(Dana-Farber Cancer Institute), Zachary T. Herbert(Dana-Farber Cancer Institute), Jennifer Y. Ge(Harvard University), Veerle W. Daniëls(Dana-Farber Cancer Institute), Franziska Michor(Dana-Farber Cancer Institute), Shaokun Shu(Peking University), Huang Xiao-Yun(Dana-Farber Cancer Institute), Alba Font‐Tello(Dana-Farber Cancer Institute)
Cell Reports
December 1, 2023
Cited by 29


Related Papers